Autopsy report · NCT01216657

Trial of Single Agent Sunitinib for Patients With Chemo-refractory Metastatic Melanoma

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“slow recruitment”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 year 1 month after it had already started.
Ran for about 4 years 2 months before it stopped.
7 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Krankenhaus Nordwest
Sponsor type: University, hospital or other
Conditions: Chemo-refractory Melanoma
Interventions: Sunitinib
Participants: 7
Sites: 1
Countries: Germany

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.